123 related articles for article (PubMed ID: 1357070)
21. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.
Lima L; Arce V; Diaz MJ; Tresguerres JA; Devesa J
J Clin Endocrinol Metab; 1993 Feb; 76(2):439-44. PubMed ID: 8094392
[TBL] [Abstract][Full Text] [Related]
22. Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation.
Giustina A; Girelli A; Alberti D; Bossoni S; Buzi F; Doga M; Schettino M; Wehrenberg WB
Clin Endocrinol (Oxf); 1991 Dec; 35(6):491-8. PubMed ID: 1769130
[TBL] [Abstract][Full Text] [Related]
23. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
[TBL] [Abstract][Full Text] [Related]
24. Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis.
Díez JJ; Iglesias P; Selgas R; Bajo MA; Aguilera A
Clin Endocrinol (Oxf); 2000 Nov; 53(5):587-93. PubMed ID: 11106919
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
Giusti M; Marini G; Sessarego P; Peluffo F; Valenti S; Caratti C; Giordano G
Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302
[TBL] [Abstract][Full Text] [Related]
26. Regulation of hypothalamic somatostatin by glucocorticoids.
Devesa J; Barros MG; Gondar M; Tresguerres JA; Arce V
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):277-82. PubMed ID: 7626468
[TBL] [Abstract][Full Text] [Related]
27. Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging.
Ghigo E; Goffi S; Arvat E; Nicolosi M; Procopio M; Bellone J; Imperiale E; Mazza E; Baracchi G; Camanni F
Acta Endocrinol (Copenh); 1990 Aug; 123(2):169-73. PubMed ID: 2220258
[TBL] [Abstract][Full Text] [Related]
28. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Cordido F; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
[TBL] [Abstract][Full Text] [Related]
29. Interaction of glucose and pyridostigmine on the secretion of growth hormone (GH) induced by GH-releasing hormone (GHRH).
Delitala G; Tomasi PA; Palermo M; Fresu P
J Endocrinol Invest; 1990 Sep; 13(8):653-6. PubMed ID: 2273206
[TBL] [Abstract][Full Text] [Related]
30. Pyridostigmine fails to increase either spontaneous or GHRH-stimulated GH secretion during day or night in growth hormone-insufficient children.
Kirk JM; Ross RJ; Trainer PJ; Froud AL; Davies SC; Savage MO; Besser GM
Clin Endocrinol (Oxf); 1991 May; 34(5):407-11. PubMed ID: 2060150
[TBL] [Abstract][Full Text] [Related]
31. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on growth hormone (GH) responses to GH-releasing hormone in patients with Cushing's syndrome.
Leal-Cerro A; Pereira JL; Garcia-Luna PP; Astorga R; Cordido F; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 1990 Aug; 33(2):291-5. PubMed ID: 2225484
[TBL] [Abstract][Full Text] [Related]
32. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
[TBL] [Abstract][Full Text] [Related]
33. Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans.
Ghigo E; Arvat E; Gianotti L; Ramunni J; Maccario M; Camanni F
Clin Endocrinol (Oxf); 1994 Jun; 40(6):799-802. PubMed ID: 8033372
[TBL] [Abstract][Full Text] [Related]
34. Pyridostigmine enhances even if it does not normalize the growth hormone responses to growth hormone-releasing hormone in patients with Cushing's disease.
Giustina A; Bossoni S; Bodini C; Ferrari C; Pizzocolo G; Scalvini T; Schettino M; Wehrenberg WB
Horm Res; 1991; 35(3-4):99-103. PubMed ID: 1806475
[TBL] [Abstract][Full Text] [Related]
35. Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats.
Giustina A; Misitano V; Voltz D; Piering A; Wehrenberg WB
Endocr Res; 1995 Nov; 21(4):719-32. PubMed ID: 8582323
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone (GH) autofeedback on GH response to GH-releasing hormone. Role of free fatty acids and somatostatin.
Pontiroli AE; Lanzi R; Monti LD; Sandoli E; Pozza G
J Clin Endocrinol Metab; 1991 Feb; 72(2):492-5. PubMed ID: 1671389
[TBL] [Abstract][Full Text] [Related]
37. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.
Arvat E; Cappa M; Casanueva FF; Dieguez C; Ghigo E; Nicolosi M; Valcavi R; Zini M
J Clin Endocrinol Metab; 1993 Feb; 76(2):374-7. PubMed ID: 8432781
[TBL] [Abstract][Full Text] [Related]
38. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
[TBL] [Abstract][Full Text] [Related]
39. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
40. Pyridostigmine enhances, but does not normalise, the GH response to GH-releasing hormone in obese subjects.
Castro RC; Vieira JG; Chacra AR; Besser GM; Grossman AB; Lengyel AM
Acta Endocrinol (Copenh); 1990 Mar; 122(3):385-90. PubMed ID: 2109445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
